[1] 曾民德. 葡萄糖毒性、脂肪毒性与非酒精性脂肪性肝病[J]. 中华肝脏病杂志,2005,l3（2）：81-82.
[2] 中华医学会肝病分会脂肪肝和酒精性肝病组. 非酒精性脂肪性肝病诊疗指南[J]. 实用肝脏病杂志,2007,10（1）：1-3.
[3] PANAGO C,SOSRDO G,ESPOSITO W,et al. Plasma adiponectin is decreased in nonalchoholic fatty liver disease[J].European Journal of Endocrinology,2005,152（1）：113-118.
[4] BARANOVA A,GOWDER SJ,SCHLAUCH K,et al. Gene expression of leptin,resistin and adiponectin in the white adipose tissue of obse patients with non-alcoholic fatty liver disease and insulin resistance[J]. Obesity Surgery,2006,16（9）：1118-1125.
[5] YAMAUCHI T,KAMON J,ITO Y,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature,2003,423（6941）：762-769
[6] TARGHER G,BERTOLINI L,RODELLA S,et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease[J]. Clinical Endocrinology,2006,64（6）：679-683.
[7] XU A,WANG Y,KESHAW H,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J]. J Clin Invest,2003,112（1）：91-100.
[8] HUI J,HODGE A,FARRELL G,et al. Beyond insulin resistance in NASH：TNF-α or adiponectin[J]. Hepatology,2004,40（1）：46-54.
[9] DING X,SAXENA NK,LIN S,et al. The roles of leptin and adiponectin：a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology[J]. Am J Pathol,2005,166：1655-1669.
[10] TAKAHASHI-YASUNO A,MASUZAKI H,MIYAWAKI T,et al. Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men[J]. Diabetes Res Clin Pract,2003,62（3）：169-175.
[11] CHITTURI S,FARRELL G,FROST L,et al. Serum leptin in NASH correlates with hepatic steatosis but not fribrosis：a manifestation of lipotoxieity[J]. Hepatology,2002,36（2）：403-409.
[12] UYGUN A,KADAYIFCI A,YESILOVA Z,et al. Serum leptin levels in patients with nonalcoholic steatohepatitis[J]. Am J Gastroentrol,2000,95（12）：3584-3589.
[13] STEPPAN CM,BAILEY ST,BHAT S,et al. The hormone resistin links obesity to diabetes[J]. Nature,2001,409（6818）：307-312.
[14] ZHOU L,LI Y,XIA T,et al. Resistin overexpression impaired glucose tolerance in hepatocytes[J]. Eur Cytokine Netw,2006,17（3）：189-195.
[15] AL-SARI IE,AL-QUOBAILI FA,KABALAN YM. Serum resistin levels in Syrian obese patients with diabetes mellitus type II[J]. Saudi Med J,2007,28（12）：1890-1894.
[16] TOKUYAMA Y,OSAWA H,ISHIZUKA T,et al. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus[J].Metabolism,2007,56（5）：693-698.
[17] KIM KH,LEE K,MOON YS,et al. A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation[J]. J Biol Chem,2001,276（14）：11252-11256.
[18] SAVA DB,SEWTER CP,KLENK ES,et al. Human resistin/Fizz3 expression in relation to obesity and peroxisome proliferators activated receptor-γ action in humans[J]. Diabetes,2001,50（10）：2199-2202.
[19] YANG RZ,HUANG Q,XU A,et al. Comparative studies of resistin expression and phylogenomics in human and mouse[J]. Biochem Biophys Res Commun,2003,310（3）：927-935.
[20] SISWAL N,SINGH AK,ARUNA B,et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway[J]. Biochem Biophys Res Commun,2005,334（4）：1092-1101.
[21] 范建高,方继伟,陆元善,等. 高脂饮食非酒精性脂肪性肝病大鼠肝脏成脂相关基因表达增强[J]. 中华消化杂志,2006,26（5）：320-323.
[22] BERTOLANI C,SANCHO-BRU P,FAILLI P,et al. Resistin as an intrahepatic cytokine：overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells[J]. Am J Pathol,2006,169（6）：2042-2053.
[23] WONG VW,HUI AY,TSANG SW,et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol,2006,4（9）：1154-1161.
[24] 林克荣,杨慧莹,张志坚,等. 非酒精性脂肪肝患者血清肿瘤坏死因子-α、脂联素水平与胰岛素抵抗的相关性[J]. 世界华人消化杂志,2007,15：2613-2618. |
